Multistage Carcinogenesis and the Incidence of Human Cancer

Genes Chromosomes and Cancer

Volumn 38, Issue 4, 2003, Pages 302-306

  Moolgavkar, Suresh H ^a   Luebeck, E Georg ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CARCINOGEN; DIOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE;

ADENOMATOUS POLYP; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; GENE MUTATION; HUMAN; IMMUNOLOGY; IONIZING RADIATION; MALIGNANT TRANSFORMATION; MATHEMATICAL MODEL; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; ENVIRONMENTAL EXPOSURE; HUMANS; INCIDENCE; NEOPLASM STAGING; NEOPLASMS;

EID: 0344844367     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10264     Document Type: Review

References (19)

1. Armitage P, Doll R. 1954. The age distribution of cancer and multistage theory of carcinogenesis. Br J Cancer 8:1-12.
2. Baron JA, Sandler RS. 2000. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 51:511-523.
3. Brown WA, Skinner SA, Malcontenti-Wilson C, Vogiagis D, O'Brien PE. 2001. Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation. Gut 48:660-666.
4. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. 1998. Mechanisms underlying nonsteroidal antinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 95:681-686.
5. Cook PJ, Doll R, Fellingham SA. 1969. A mathematical model for the age distribution of cancer in man. Int J Cancer 4:93-112.
6. Dewanji A, Moolgavkar SH, Luebeck EG. 1991, Two-mutation model for carcinogenesis: joint analysis of premalignant and malignant lesions. Math Biosci 104:97-109.
7. Doll R, Peto R. 1978. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 32:303-313.
8. Hazelton WD, Luebeck EG, Heidenreich WF, Moolgavkar SH. 2001. Analysis of a historical cohort of Chinese tin miners with arsenic, radon, cigarette, and pipe smoke exposures using the biologically-based two-stage clonal expansion model. Radiat Res 156:78-94.
9. Heidenreich W, Luebeck EG, Moolgavkar SH. 1997. Some properties of the hazard function of the two-mutation clonal expansion model. Risk Anal 17:391-399.
10. Heidenreich WF, Atkinson M, Paretzke HG. 2001. Radiation-induced cell inactivation can increase the cancer risk. Radiat Res 155:870-872.
11. Herrero-Jimenez P, Thilly G, Southam PJ, Tomita-Mirchell A, Morgenthaler S, Furth EE, Thilly WG. 1998. Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States. Mutat Res 400:553-578.
12. Knudson AG. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sciences USA 68:820-823.
13. Luebeck EG, Moolgavkar SH. 2002. Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci USA 99:15095-15100.
14. Luria SE, Delbruck M. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.
15. Moolgavkar SH, Venzon DJ. 1979. Two-event model for carcinogenesis: incidence curves for childhood and adult tumors. Math Biosci 47:55-77.
16. Moolgavkar SH, Luebeck G. 1990. Two-event model for carcinogenesis: biological, mathematical and statistical considerations. Risk Anal 10:323-341.
17. Moolgavkar SH, Krewski D, Schwarz M. 1999. Mechanisms of carcinogenesis and biologically-based models for quantitative estimation and prediction of cancer risk. In: Moolgavkar SH, Krewski D, Zeise L, Cardis E, Moller H, editors. Quantitative estimation and prediction of cancer risk. Lyons: IARC Scientific Publications. p. 179-238.
18. Nordling CO. 1953. A new theory of the cancer inducing mechanism. Br J Cancer 7:68-72.
19. Prehn RT. 1975. Nongenetic variability in susceptibility to oncogenesis. Science 190:1095-1096.